One investigation, a comparative study between WT1 IHC antibodies, used the newer clone WT49 and the conventional clone 6F-H2 to stain 40 malignant pleural mesotheliomas, 55 lung carcinomas and 10 intrathoracic synovial sarcomas [161], and their results corroborate with ours. The gene discussed is WT1; the disease is lung carcinoma.